Clinical neuropsychiatry and neuropsychology

Researchers

  • Anna Planas Ballvé

    Clinical neuropsychiatry and neuropsychology

  • Asunción Ávila

    Clinical neuropsychiatry and neuropsychology

    Phd
  • Dolores Lozano

    Clinical neuropsychiatry and neuropsychology

  • Ester Moral Torres

    Clinical neuropsychiatry and neuropsychology

  • Irati Zubizarreta

    Clinical neuropsychiatry and neuropsychology

    Phd
  • Joan Bello López

    Clinical neuropsychiatry and neuropsychology

    Phd
  • José Vicente Hervas-garcía

    Clinical neuropsychiatry and neuropsychology

    Phd
  • Juan Bernardo Gómez

    Clinical neuropsychiatry and neuropsychology

  • Juan José Mengual

    Clinical neuropsychiatry and neuropsychology

  • Laura Gubieras Lillo

    Clinical neuropsychiatry and neuropsychology

  • Mª Isabel Gómez Ruiz

    Clinical neuropsychiatry and neuropsychology

    Phd
  • Marta Balagué

    Clinical neuropsychiatry and neuropsychology

  • Mercè Leixà

    Clinical neuropsychiatry and neuropsychology

  • Mireia Grau

    Clinical neuropsychiatry and neuropsychology

  • Monica Prat

    Clinical neuropsychiatry and neuropsychology

  • Montse Vacas Moreira

    Clinical neuropsychiatry and neuropsychology

  • Nuria Caballol

    Clinical neuropsychiatry and neuropsychology

  • Pablo Millet Balance

    Clinical neuropsychiatry and neuropsychology

  • Sonia Maria Garcia

    Clinical neuropsychiatry and neuropsychology

  • Xavier Cardona

    Clinical neuropsychiatry and neuropsychology

Contact the group

Form
  • Calabria M, Hernández M, Cattaneo G, Suades A, Serra M, Juncadella M, Rene R, Sala I, Lleo A, Ortiz-Gil J, Ugas L, Ávila A, Gómez-Ruiz I, Ávila C, Costa A. 196 /20

    Active bilingualism delays the onset of mild cognitive impairment.

    Neuropsychology. 2020 Sep;146:107528.
  • Crespo-Cuevas AM, Canento T, Hernández-Pérez M, Cáceres C, González A, Ispierto L, Mataro M, Vilas D, Planas-Ballvé A, Martín L, Muñoz-Ortiz L, Arenillas JF, Via M. Castanon M, Millan M, Dorado L, López-Cancio E. 316/20

    The Barcelona-Asymptomatic Intracranial Atherosclerosis (AsIA) study: Subclinical cervico-cerebral stenosis and middle cerebral artery pulsatility index as predictors of long-term incident cognitive impairment.

    Atherosclerosis 2020 Nov;312:104-109
  • Santos García D, López Ariztegui N, Cubo E, Vinagre Aragón A, García-Ramos R, Borrué C, Fernández-Pajarín G, Caballol N, Cabo I, Barrios-López JM, Hernández Vara J, Ávila Rivera MA, Gasca-Salas C, Escalante S, Manrique de Lara P, Pérez Noguera R, Álvarez Sauco M, Sierra M, Monje MHG, Sánchez Ferro A, Novo Ponte S, Alonso-Frech F, Macías-García D, Legarda I, Rojo A, Álvarez Fernández I, Buongiorno MT, Pastor P, García Ruíz P. 214/20

    Clinical utility of a personalized and long-term monitoring device for Parkinson's disease in a real clinical practice setting: An expert opinion survey on STAT-ON™.

    neurology 2020 Dec 24;S0213-4853(20)30339-X.
  • Santos-Garcia D, de Deus Fonticoba T, Suarez Castro E, Aneiros Diaz A, Cores Bartolome C, Feal Panceiras MJ, Paz Gonzalez JM, Valdés Aymerich L, Garcia Moreno JM, Blázquez Estrada M, Jesús S, Mir P, Aguilar M , Planellas LL, Garcia Caldentey J, Caballol N, Legarda I, Cabo López I, Lopez Manzanares L, Ávila Rivera MA, Catalán MJ, López Diaz LM, Borrue C, Álvarez Sauco M, Vela L, Cubo E, Martinez Castrillo JC, Sanchez Alonso P, Alonso Losada MG, López Ariztegui N, Gaston I, Pascual-Sedano B, Seijo M, Ruiz Martinez J, Valero C, Kurtis M, González Ardura J, Prieto Jurczynska C, Martinez-Martin P. 292/20

    Quality of life and non-motor symptoms in Parkinson's disease patients with subthreshold depression.

    J Neurol Sci. 2020 Aug 28;418:117109
  • Santos-García D, de Deus Fonticoba T, Suárez Castro E, Aneiros Díaz A, McAfee D, Catalán MJ, Alonso-Frech F, Villanueva C, Jesús S, Mir P, Aguilar M, Pastor P, García Caldentey J, Estelrich Peyret E, Planellas LL, Martí MJ, Caballol N, Hernández Vara J, Martí Andrés G, Cabo I, Ávila Rivera MA, López Manzanares L, Redondo N, Martinez-Martin P; COPPADIS Study Group, McAfee D. 272/20

    Non-motor symptom burden is strongly correlated to motor complications in patients with Parkinson's disease.

    Eur J Neurol. 2020 Jul;27(7):1210-1223.
  • Santos-García D, De Deus FT, Cores BC, Valdés AL, Suárez CE, Aneiros Á, Jesús S, Aguilar M, Pastor P, Planellas L, Cosgaya M, García CJ, Caballol N, Legarda I, Hernández VJ, Cabo I , López ML, González AI, Ávila MA, José CM, Nogueira V, Puente V, García MJM, Borrué C, Solano VB, Álvarez SM, Vela L, Escalante S, Cubo E, Carrillo PF, Martínez CJC, Sánchez AP, Alonso LMG, López AN, Gastón I, Kulisevsky J, Blázquez EM, Seijo M, Rúiz MJ, Valero C, Kurtis M, de Fábregues-Boixar O, González AJ, Prieto JC, López DL, McAfee D, Mir P; COPPADIS Study Group. 267/20

    Mood in Parkinson's disease: From early- to late-stage disease.

    Int J Geriatric Psychiatry. 2020 Nov 10.
  • Santos-García D, de Deus-Fonticoba T, Suárez Castro E, M Aneiros Díaz Á, Feal-Painceiras MJ, Paz-González JM, García-Sancho C, Jesús S, Mir P, Planellas L, García-Caldentey J, Caballol N, Legarda I, Hernández-Vara J, González-Aramburu I, Ávila-Rivera MA, Catalán MJ, Nogueira V, Álvarez-Sauco M, Vela L, Escalante S, Cubo E, Sánchez-Alonso P, Alonso-Losada MG, López-Ariztegui N, Martinez-Martin P; COPPADIS Study Group. 319/20

    The impact of freezing of gait on functional dependency in Parkinson's disease with regard to motor phenotype.

    Neurol Sci. 2020 Oct;41(10):2883-2892.
  • Santos-García D, Suárez Castro E, de Deus Fonticoba T, Feal Panceiras MJ, Muñoz Enriquez JG, Paz González JM, Cores Bartolomé C, Planellas LL, García Caldentey J, Caballol N, Legarda I, Cabo López I, López Manzanares L , Ávila Rivera MA, Catalán MJ, Nogueira V, Borrué C, Álvarez Sauco M, Vela L, Cubo E, Martínez Castrillo JC, Sánchez Alonso P, Alonso Losada MG, López Ariztegui N, Gastón MI, Kulisevsky J, Pagonabarraga J, Seijo M, Ruíz Martínez J, Valero C, Kurtis M, González Ardura J, Prieto C, Mir P, Martinez-Martin P. 310/20

    Sleep Problems Are Related to a Worse Quality of Life and a Greater Non-Motor Symptoms Burden in Parkinson's Disease.

    J Geriatric Psychiatry Neurol. 2020 Oct 12;891988720964250
  • Ávila A, Caballol N, Martín-Baranera M, Gómez-Ruiz I, Balagué-Marmaña M, Planas-Ballvé A, Cardona X. 142/19

    Rasagiline and safinamide as a dopamine sparing therapy for Parkinson's disease.

    Acta Neurol Scand. 2019;140(1):23-31.
  • Gómez-Choco M, Mengual JJ, Rodríguez-Antigüedad J, Paré-Curell M, Purroy F, Palomeras E, Fuentes B, Ustrell X, Tembl J, Rodríguez-Yañez M, Castellanos M, Martí-Fabregas J, Serena J. 101 /19

    Pre-Existing Cerebral Small Vessel Disease Limits Early Recovery in Patients with Acute Lacunar Infarct.

    J Stroke Cerebrovasc Dis. 2019;28(11):104312.

Projects

  • Clinical neuropsychiatry and neuropsychology

    Researcher
    • Year 2020
    • HSDMB

    Evaluation of the perception of people with advanced multiple sclerosis on their socio-health needs and quality of life: an exploratory cross-sectional observational epidemiological study.

    • DISTRICT ATTORNEY:

      Multiple Sclerosis Spain

    • TYPE E:

      EPA-OD

  • Clinical neuropsychiatry and neuropsychology

    Researcher
    • Year 2020
    • HSDMB

    Observational, transversal, non-interventionist and multicenter study for the characterization of gait in patients with Relapsing-Recurrent Multiple Sclerosis and Secondary Progressive Multiple Sclerosis measured by the sensor system integrated in the FeetMe® insole. MS-FEET Pro,

    • DISTRICT ATTORNEY:

      Novartis Pharmaceuticals SA

    • TYPE E:

      PS

  • Clinical neuropsychiatry and neuropsychology

    Researcher
    • Year 2020
    • HSDMB

    Prospective study to evaluate the clinical and immunological evolution of patients with multiple sclerosis in disease-modifying treatment infected versus not infected by SARS-COV-2.

    • DISTRICT ATTORNEY:

      Dr. Luis Brieva Ruiz from Hospital Arnau de Vilanova de Lleida

    • TYPE E:

      EPA-AS

  • Clinical neuropsychiatry and neuropsychology

    Researcher
    • Year 2020
    • HSDMB

    A 2-year follow-up study to assess cognition and health-related quality of life in participants with highly active relapsing multiple sclerosis, having participated in the CLARIFY MS trial.

    • DISTRICT ATTORNEY:

      Merck Healthcare KGaA, Darmstadt

    • TYPE E:

      RD2015

  • Clinical neuropsychiatry and neuropsychology

    Researcher
    • Year 2020
    • HSDMB

    Dendritic cell therapy combined with immunomodulatory treatment in the treatment of multiple sclerosis.

    • DISTRICT ATTORNEY:

      IDIBAPS (Institute of Biomedical Research August Pi i Sunyer)

    • TYPE E:

      RD2015

  • Clinical neuropsychiatry and neuropsychology

    Researcher
    • Year 2020
    • HSDMB

    The Prevalence and Burden of Headache Disorders in the Children and Adolescents of Catalonia.

    • DISTRICT ATTORNEY:

      Dr. Juan Bernardo Gómez Galván

    • TYPE E:

      PI

  • Clinical neuropsychiatry and neuropsychology

    Researcher
    • Year 2020
    • HSDMB

    Randomised, double-blind, placebo-controlled, clinical study to evaluate the effect of opicapone 50 mg on Parkinson's disease patients with motor fluctuations and associated pain.

    • DISTRICT ATTORNEY:

      Bial - Portela & Ca, SA

    • TYPE E:

      RD2015

    • Year 2020
    • HSDMB

    Evaluation of the perception of people with advanced multiple sclerosis on their socio-health needs and quality of life: an exploratory cross-sectional observational epidemiological study.

    • DISTRICT ATTORNEY:

      Multiple Sclerosis Spain

    • TYPE E:

      EPA-OD

    • Year 2020
    • HSDMB

    A 2-year follow-up study to assess cognition and health-related quality of life in participants with highly active relapsing multiple sclerosis, having participated in the CLARIFY MS trial.

    • DISTRICT ATTORNEY:

      Merck Healthcare KGaA, Darmstadt

    • TYPE E:

      RD2015

    • Year 2020
    • HSDMB

    Dendritic cell therapy combined with immunomodulatory treatment in the treatment of multiple sclerosis.

    • DISTRICT ATTORNEY:

      IDIBAPS (Institute of Biomedical Research August Pi i Sunyer)

    • TYPE E:

      RD2015

Lines of action

  • Parkinson's disease in our area
  • Psychiatric pathology in neurological diseases
  • Bilingualism in dementia, stroke and movement disorders
  • Multiple Sclerosis: treatment and quality of life
  • Cognitive and fluid biomarkers in neurodegenerative disorders

Documents

Information of interest

Links